AAPACN is dedicated to supporting post-acute care nurses provide quality care.

FDA Alert: SARS-CoV-2 Viral Mutation Could Cause False Negatives on Tests, but Overall Risk Is Low (1/21)

Impact on molecular tests remains low January 08, 2021 The U.S. Food and Drug Administration is alerting clinical laboratory staff and health care providers that the FDA is monitoring the potential impact of viral mutations,...

Oops! This is member-only content.

Please login, sign up for a full membership, or sign up for a free 30-day trial membership to access this content.

Copy link
Powered by Social Snap